| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.04.23 | Ikonisys SA: Ikonisys publishes its Full-Year Financial Results for 2022 and provides an update on its latest developments | 933 | Business Wire | A year marked by significative strategic investments and by the first sale of the Ikoniscope20 solution, including newly added reagents in partnership with Empire Genomics, to the first US customer... ► Artikel lesen | |
| 29.04.23 | Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer | 727 | Business Wire | Results at the American Urological Association's 2023 Annual Meeting (AUA2023)
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative... ► Artikel lesen | |
| 29.04.23 | Arm Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering | 648 | Business Wire | Arm today announced that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public... ► Artikel lesen | |
| 29.04.23 | Lysogene Announces Postponement of 2022 Financial Results Release | 633 | Business Wire | Regulatory News:
Lysogene (FR0013233475 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces that it will not be able to release its 2022 financial... ► Artikel lesen | |
| 29.04.23 | AVANGRID, Inc.: Massive Shareholder Support for Management of AVANGRID's Parent Company Iberdrola in a Record Year for the Company | 1.646 | Business Wire | MASSIVE SHAREHOLDER SUPPORT FOR MANAGEMENT OF AVANGRID'S PARENT COMPANY IBERDROLA IN A RECORD YEAR FOR THE COMPANY The company held its Annual General Meeting of Shareholders at the Torre Iberdrola... ► Artikel lesen | |
| 29.04.23 | The Estée Lauder Companies Inc.: Die Marke TOM FORD präsentiert ihr Geschäftsführungsteam | 996 | Business Wire | Guillaume Jesel wird President und CEO, TOM FORD Peter Hawkings wird Creative Director, TOM FORD
Die Marke TOM FORD, die jetzt zu The Estée Lauder Companies Inc. (NYSE:EL) gehört, hat die Ernennung... ► Artikel lesen | |
| 29.04.23 | Akanda Corp. meldet Darlehensvereinbarung | 914 | Business Wire | Das internationale Unternehmen für medizinische Cannabisplattformen Akanda Corp. ("Akanda" oder das "Unternehmen") (NASDAQ: AKAN, WKN: A3DG83) gibt bekannt, dass es eine auf den 26. April 2023 datierte... ► Artikel lesen | |
| 29.04.23 | Brigade-M3 European Acquisition Corp. legt Jahresbericht 2022 vor | 726 | Business Wire | Die Brigade-M3 European Acquisition Corp. (das "Unternehmen"), eine zweckgebundene Akquisitionsgesellschaft, die am 21. April 2021 nach dem Recht der Cayman Islands als befreite Gesellschaft mit beschränkter... ► Artikel lesen | |
| 29.04.23 | Selina Hospitality PLC Reports Fiscal 2022 Financial Results | 415 | Business Wire | NEW YORK--(BUSINESS WIRE)--Selina Hospitality PLC ("Selina"; NASDAQ: SLNA), the fast-growing experiential hospitality brand targeting millennial and Gen Z travelers, announced today its financial... ► Artikel lesen | |
| 29.04.23 | Brigade-M3 European Acquisition Corp. 2022 Annual Report | 522 | Business Wire | Brigade-M3 European Acquisition Corp. (the "Company"), a special purpose acquisition company that was incorporated on 21 April 2021 under the laws of the Cayman Islands as an exempted company with... ► Artikel lesen | |
| 29.04.23 | The Estée Lauder Companies Inc.: The Estée Lauder Companies schließt Übernahme der Marke Tom Ford ab | 694 | Business Wire | ELC vergibt Lizenzen für die Marke TOM FORD an Zegna Group für Mode und Accessoires sowie an Marcolin Group für Brillen
The Estée Lauder Companies Inc. (NYSE: EL) ("ELC") gab heute bekannt, dass... ► Artikel lesen | |
| 29.04.23 | Teva and MedinCell Announce FDA Approval of UZEDY (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults | 980 | Business Wire | This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a Phase 3 clinical trial, UZEDY demonstrated... ► Artikel lesen | |
| 29.04.23 | Teva Pharmaceutical Industries Limited: Teva and MedinCell Announce FDA Approval of UZEDY (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults | 3.816 | Business Wire | This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a Phase 3 clinical trial, UZEDY demonstrated... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.524 |
| NEL | 1.481 |
| APPLE | 1.383 |
| BAYER | 1.295 |
| BYD | 1.289 |
| SUPER MICRO COMPUTER | 1.205 |
| DEUTSCHE BANK | 1.110 |
| TUI | 1.082 |
| NVIDIA | 1.046 |
| PLUG POWER | 923 |
| DAIMLER TRUCK | 880 |
| TESLA | 878 |
| MERCEDES-BENZ | 811 |
| RWE | 786 |
| RHEINMETALL | 773 |
| AURUBIS | 734 |
| RENK GROUP | 698 |
| VOLKSWAGEN | 687 |
| DEUTSCHE LUFTHANSA | 679 |
| COMMERZBANK | 673 |
| AMAZON | 638 |
| SIEMENS ENERGY | 631 |
| AIXTRON SE | 598 |
| SIXT SE VZ | 581 |
| NOVO NORDISK | 544 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
